Rank;Global Rank;Institution;Country;Sector
1;51;Novartis Farma, S.p.A., Italy;ITA;Companies
2;142;Philips Research Eindhoven;NLD;Companies
3;178;Bruker Corporation;DEU;Companies
4;193;Merck KGaA, Germany;DEU;Companies
5;207;IMEC International;BEL;Companies
6;212;Novartis, Switzerland;CHE;Companies
7;217;AstraZeneca, United Kingdom;GBR;Companies
8;259;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
9;289;GlaxoSmithKline, Belgium;BEL;Companies
10;327;France Telecom, S.A.;FRA;Companies
11;348;Bayer AG Germany;DEU;Companies
12;391;GlaxoSmithKline, United Kingdom;GBR;Companies
13;421;BASF AG;DEU;Companies
14;442;VTT Technical Research Centre of Finland;FIN;Companies
15;444;Siemens AG;DEU;Companies
16;471;Novo Nordisk A/S;DNK;Companies
17;549;Hoffmann-La Roche, Ltd., Switzerland;CHE;Companies
18;595;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
19;757;Daimler AG;DEU;Companies
20;777;STMicroelectronics;ITA;Companies
21;994;Pfizer Inc., United Kingdom;GBR;Companies
22;1134;SINTEF Group;NOR;Companies
23;1302;AstraZeneca, Sweden;SWE;Companies
23;1302;Thales Group France, S.A.;FRA;Companies
25;1351;Robert Bosch GmbH;DEU;Companies
26;1960;Microsoft Research Cambridge;GBR;Companies
27;2143;STMicroelectronics;FRA;Companies
28;2185;SAP AG;DEU;Companies
29;2400;Infineon Technologies;DEU;Companies
30;2628;Sincrotrone Trieste;ITA;Companies
31;3062;Atomic Weapons Establishment;GBR;Companies
31;3062;BMJ Group;GBR;Companies
31;3062;BMW AG;DEU;Companies
31;3062;Electricite de France, S.A.;FRA;Companies
31;3062;Rolls-Royce plc;GBR;Companies
31;3062;Syngenta, United Kingdom;GBR;Companies